Financials
Income statement
Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 2.5B | 2.9B | 2.7B |
Cost of revenue | 1.0B | 1.2B | 1.4B | 1.3B |
Gross profit | 1.1B | 1.3B | 1.5B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 505.3M | 491.3M | 491.2M | 462.2M |
Other operating expenses | — | — | — | — |
Operating income | 609.4M | 793M | 1.0B | 941.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 100.2M | 104.4M | 104M | 102.8M |
Other income expense | -851.8M | -15M | -2.3B | 81.7M |
Pretax income | -342.6M | 673.6M | -1.3B | 920.8M |
Tax provision | 28M | 44.5M | -152.2M | 28M |
Net income | -370.6M | 629.1M | -1.2B | 892.8M |
Basic EPS | — | 3.4 | -6.6 | 4.8 |
Diluted EPS | — | 3.4 | -6.6 | 4.8 |
Basic average shares | — | 181.2M | 181.9M | 182.8M |
Diluted average shares | — | 181.8M | 181.9M | 183.5M |
EBITDA | 712.4M | 935.9M | 1.1B | 1.1B |
Net income from continuing op. | -370.6M | 629.1M | -1.2B | 892.8M |
Minority interests | -4.7M | -13.2M | -16.6M | -15.8M |
Preferred stock dividends | — | — | — | — |